Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): A randomised, open-label phase 3 trial

Andrew E. Place, Kristen E. Stevenson, Lynda M. Vrooman, Marian H. Harris, Sarah K. Hunt, Jane E. O'Brien, Jeffrey G. Supko, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Peter D. Cole, Kara M. Kelly, Caroline Laverdiere, Jean Marie Leclerc, Bruno Michon, Marshall A. Schorin, Jennifer J.G. Welch, Steven E. Lipshultz, Jeffery L. Kutok, Traci M. BlonquistDonna S. Neuberg, Stephen E. Sallan, Lewis B. Silverman

Research output: Contribution to journalArticlepeer-review

109 Scopus citations

Fingerprint

Dive into the research topics of 'Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): A randomised, open-label phase 3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences